Riskpilot← Back to searchSign inGet full accessWeco Biotech ApS
APSActiveCVR 36938587Rungsted Strandvej 113Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2015— employees
Revenue 2025
DKK -83K
+14% vs 2024
EBITDA margin
100.0%
-14% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
DKK -542K
-102% vs 2024
| Revenue | DKK -83K | +14% |
| EBITDA | DKK -83K | -14% |
| Net profit | DKK -542K | -102% |
| Total assets | DKK 229,1M | -1% |
| Equity | DKK 229,1M | +0% |
| Employees | — | — |
Legal name
Weco Biotech ApS
CVR number
36938587
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
26. juni 2015
Share capital
DKK 200.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er indirekte som holdingselskab at eje kapitalandele i andre selskaber indenfor biotek branchen
Address
Rungsted Strandvej 113
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -162 | — | — | — | — | — | — | — | -66 | -73 | -83 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -162 | -27 | -41 | 363.331 | 243.650 | 292.089 | -595.050 | -208.099 | -66 | -73 | -83 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -162 | -27 | -41 | 363.331 | 243.650 | 292.089 | -595.050 | -208.099 | -66 | -73 | -83 |
| Net financials | 0 | 182 | 184 | 363.539 | 243.880 | 292.321 | -594.812 | -207.810 | 35.442 | 35.237 | 776 |
| Profit before tax | -162 | 155 | 143 | 363.514 | 243.834 | 292.287 | -594.848 | -207.838 | 35.376 | 35.164 | 693 |
| Tax | -24 | 22 | 31 | 35 | 30 | 36 | -0 | -0 | 96 | 103 | 1.235 |
| Net profit | -138 | 133 | 112 | 363.479 | 243.804 | 292.251 | -594.848 | -207.838 | 35.280 | 35.061 | -542 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6.888 | 7.042 | 7.200 | 427.147 | 671.031 | 963.337 | 367.537 | 159.738 | 195.209 | 230.488 | 229.139 |
| Equity | 6.798 | 6.931 | 7.043 | 426.941 | 670.745 | 962.996 | 367.152 | 159.314 | 194.594 | 229.655 | 229.113 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 89 | 111 | 157 | 206 | 286 | 341 | 385 | 424 | 615 | 833 | 26 |
| Total debt | 89 | 111 | 157 | 206 | 286 | 341 | 385 | 424 | 615 | 833 | 26 |
EBITDA margin
-8300000.0%
This company
15.8%
Market median
-52531746% vs market
20152025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20152025
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20152025
Net profit margin
-54200000.0%
This company
8.1%
Market median
-669135902% vs market
20152025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20152025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20152025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-06-26 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JE Management | Management | 2015 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
WECO A/S | Company | 100.0% | 100.0% | 2025 |
MAGAZZINO HOLDING ApS | Company | 10.0% | 10.0% | 2015 |
LJ BULK INVEST ApS | Company | 5.0% | 5.0% | 2015 |
WW24122015 ApS | Company | 10.0% | 10.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
WECO A/S
Weco Biotech ApS Board members of Weco Biotech ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Ernst Wedell-Wedellsborg | Management | 0 companies |